Akebia Therapeutics, Inc.

AKBANASDAQHealthcare● Active

$0.92

$-0.02(-2.05%)

Market Cap$245751153

P/E Ratio—

52W High$4.079

52W Low$0.875

Avg Volume3.6M

Open$0.95

Beta0.25

Employees Ownership Insider Trades

Akebia Therapeutics, Inc. (AKBA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AKBA · as of Feb 26, 2026

Latest filing snapshot

194

+13+7.18%vs prior year

Akebia Therapeutics, Inc. (AKBA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

194

Change (1Y)

+13

Growth % (1Y)

+7.18%

Revenue / Employee

$1.22M

Net Income / Employee

$-27.6K

Market Cap

$244M

AKBA Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	194	+13	+7.18%
2025-03-13	2024-12-31	181	+14	+8.38%
2024-03-14	2023-12-31	167	-38	-18.54%
2023-03-10	2022-12-31	205	-221	-51.88%
2022-03-01	2021-12-31	426	+46	+12.11%
2021-02-25	2020-12-31	380	+20	+5.56%
2020-03-12	2019-12-31	360	+35	+10.77%
2019-03-26	2018-12-31	325	+211	+185.09%
2018-03-12	2017-12-31	114	+24	+26.67%
2017-03-06	2016-12-31	90	+26	+40.63%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

FDMT

4D Molecular Therapeutics, Inc.

227$449M #2

AKBA

Akebia Therapeutics, Inc.YOU

194$244M #3

KALV

KalVista Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

96$883M #6

CMPX

Compass Therapeutics, Inc.

35$279M #7

CRVS

Corvus Pharmaceuticals, Inc.

31$942M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AKBA peer comparison

About AKBA employees

AKBA Employees · Headcount

Akebia Therapeutics, Inc. (AKBA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Akebia Therapeutics, Inc. had 194 full-time employees globally. Full-time employees only. Global consolidated headcount.

Akebia Therapeutics, Inc. employs 194 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.22M, reflecting the company's operational efficiency.

Akebia Therapeutics, Inc.'s workforce increased by 13 (7.18%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Akebia Therapeutics, Inc.'s revenue per employee of $1.22M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AKBA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Akebia Therapeutics, Inc. had 194 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Akebia Therapeutics, Inc. employee counthow many employees does Akebia Therapeutics, Inc. haveAKBA total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26